Valeant to buy PreCision Dermatology for $475 mln-Reuters

Valeant Pharmaceuticals International Inc said on Monday it has agreed to acquire privately held PreCision Dermatology Inc for $475 million in cash to strengthen its skin products business.

3 February 2014•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles